Cross-Sector entity
J.M. Smucker is most often covered alongside CRA International, which appears in 5 of these 6 stories. The clearest coverage concentration is earnings: 4 of 6 stories, with the rest divided among 2 other categories. 0% of these stories carry negative sentiment.
6 verified stories tracked
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
J.M. Smucker is most often covered alongside CRA International, which appears in 5 of these 6 stories. The clearest coverage concentration is earnings: 4 of 6 stories, with the rest divided among 2 other categories. 0% of these stories carry negative sentiment. The tracked stories average 4.5 original sources each. J.M. Smucker appears in 6 tracked Cross-Sector stories published from February 25, 2026 through February 26, 2026.
Computed from the 6 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering J.M. Smucker. Shared-story counts are live from our verified record — not editorial picks.
Revolve Group and J.M. Smucker both saw significant stock price appreciation following their latest financial disclosures. The gains reflect a bifurcated but strong consumer environment where both high-end fashion and essential pantry staples are outperforming market forecasts.
Source: markets.financialcontent.com · markets.financialcontent.com
A diverse group of industry leaders, including search giant Elastic and consulting firm CRA International, are set to report Q4 results on February 26. The upcoming disclosures will provide critical insights into enterprise AI adoption and the health of professional services in a shifting macroeconomic environment.
A diverse group of mid-to-large cap companies across consumer staples, healthcare, and tech are set to report Q4 results tomorrow. Investors are looking for signs of margin expansion amid stabilizing inflation and the impact of generative AI on software demand.
Viatris (VTRS) and CRA International (CRAI) are scheduled to report Q4 results on February 26, 2026, providing critical insights into the generic drug market and life sciences consulting demand. These reports come as the industry faces significant regulatory and pricing headwinds from the Inflation Reduction Act and a shifting biosimilar landscape.
A diverse group of companies, including J.M. Smucker and Xponential Fitness, are set to report Q4 earnings on February 26, 2026. These reports will provide critical insights into consumer spending patterns across staples, boutique fitness, and enterprise search technology.
Viatris and CRA International are scheduled to report Q4 results tomorrow, providing critical insights into the generic pharmaceutical landscape and life sciences consulting demand. These reports come as the industry grapples with pricing pressures, regulatory shifts, and a stabilizing post-pandemic consulting market.
Source: markets.financialcontent.com · markets.financialcontent.com
